Neuroblastoma Treatment Market Size, Share, Analysis, Growth Report 2032

• Chapter No. 1 Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2 Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Therapy
      • 2.1.1.2. Market Attractiveness Analysis, By Distribution Channel
      • 2.1.1.3. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Neuroblastoma Treatment Market, 2016 – 2028 (USD Million)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3 COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4 Neuroblastoma Treatment Market – Therapy Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Therapy, 2020 & 2028
  • 4.2. Surgery
    • 4.2.1. Market Size and Forecast, By Region (USD Million)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Chemotherapy
    • 4.3.1. Market Size and Forecast, By Region (USD Million)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Immunotherapy
    • 4.4.1. Market Size and Forecast, By Region (USD Million)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Radiotherapy
    • 4.5.1. Market Size and Forecast, By Region (USD Million)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 5 Neuroblastoma Treatment Market – Distribution Channel Segment Analysis
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By Distribution Channel, 2020 & 2028
  • 5.2. Hospital Pharmacies
    • 5.2.1. Market Size and Forecast, By Region (USD Million)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Retail Pharmacies
    • 5.3.1. Market Size and Forecast, By Region (USD Million)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.4. Drug Stores
    • 5.4.1. Market Size and Forecast, By Region (USD Million)
    • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 6 Neuroblastoma Treatment Market – Regional Analysis
  • 6.1. Overview
    • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 6.2.2. North America Market Revenue, By Therapy, 2016 – 2028
    • 6.2.3. North America Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.2.4. U.S.
      • 6.2.4.1. U.S. Market Revenue, By Therapy, 2016 – 2028
      • 6.2.4.2. U.S. Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.2.5. Canada
      • 6.2.5.1. Canada Market Revenue, By Therapy, 2016 – 2028
      • 6.2.5.2. Canada Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.2.6. Mexico
      • 6.2.6.1. Mexico Market Revenue, By Therapy, 2016 – 2028
      • 6.2.6.2. Mexico Market Revenue, By Distribution Channel, 2016 – 2028
  • 6.3. Europe
    • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 6.3.2. Europe Market Revenue, By Therapy, 2016 – 2028
    • 6.3.3. Europe Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.3.4. Germany
      • 6.3.4.1. Germany Market Revenue, By Therapy, 2016 – 2028
      • 6.3.4.2. Germany Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.3.5. France
      • 6.3.5.1. France Market Revenue, By Therapy, 2016 – 2028
      • 6.3.5.2. France Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.3.6. U.K.
      • 6.3.6.1. U.K. Market Revenue, By Therapy, 2016 – 2028
      • 6.3.6.2. U.K. Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.3.7. Italy
      • 6.3.7.1. Italy Market Revenue, By Therapy, 2016 – 2028
      • 6.3.7.2. Italy Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.3.8. Spain
      • 6.3.8.1. Spain Market Revenue, By Therapy, 2016 – 2028
      • 6.3.8.2. Spain Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.3.9. Rest of Europe
      • 6.3.9.1. Rest of Europe Market Revenue, By Therapy, 2016 – 2028
      • 6.3.9.2. Rest of Europe Market Revenue, By Distribution Channel, 2016 – 2028
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 6.4.2. Asia Pacific Market Revenue, By Therapy, 2016 – 2028
    • 6.4.3. Asia Pacific Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.4.4. China
      • 6.4.4.1. China Market Revenue, By Therapy, 2016 – 2028
      • 6.4.4.2. China Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.4.5. Japan
      • 6.4.5.1. Japan Market Revenue, By Therapy, 2016 – 2028
      • 6.4.5.2. Japan Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.4.6. India
      • 6.4.6.1. India Market Revenue, By Therapy, 2016 – 2028
      • 6.4.6.2. India Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.4.7. South Korea
      • 6.4.7.1. South Korea Market Revenue, By Therapy, 2016 – 2028
      • 6.4.7.2. South Korea Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.4.8. South-East Asia
      • 6.4.8.1. South-East Asia Market Revenue, By Therapy, 2016 – 2028
      • 6.4.8.2. South-East Asia Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.4.9. Rest of Asia Pacific
      • 6.4.9.1. Rest of Asia Pacific Market Revenue, By Therapy, 2016 – 2028
      • 6.4.9.2. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2016 – 2028
  • 6.5. Latin America
    • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 6.5.2. Latin America Market Revenue, By Therapy, 2016 – 2028
    • 6.5.3. Latin America Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.5.4. Brazil
      • 6.5.4.1. Brazil Market Revenue, By Therapy, 2016 – 2028
      • 6.5.4.2. Brazil Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.5.5. Argentina
      • 6.5.5.1. Argentina Market Revenue, By Therapy, 2016 – 2028
      • 6.5.5.2. Argentina Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.5.6. Rest of Latin America
      • 6.5.6.1. Rest of Latin America Market Revenue, By Therapy, 2016 – 2028
      • 6.5.6.2. Rest of Latin America Market Revenue, By Distribution Channel, 2016 – 2028
  • 6.6. The Middle-East and Africa
    • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
    • 6.6.2. The Middle-East and Africa Market Revenue, By Therapy, 2016 – 2028
    • 6.6.3. The Middle-East and Africa Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.6.4. GCC Countries
      • 6.6.4.1. GCC Countries Market Revenue, By Therapy, 2016 – 2028
      • 6.6.4.2. GCC Countries Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.6.5. South Africa
      • 6.6.5.1. South Africa Market Revenue, By Therapy, 2016 – 2028
      • 6.6.5.2. South Africa Market Revenue, By Distribution Channel, 2016 – 2028
    • 6.6.6. Rest of Middle-East Africa
      • 6.6.6.1. Rest of Middle-East Africa Market Revenue, By Therapy, 2016 – 2028
      • 6.6.6.2. Rest of Middle-East Africa Market Revenue, By Distribution Channel, 2016 – 2028
• Chapter No. 7 Neuroblastoma Treatment Market – Industry Analysis
  • 7.1. Introduction
  • 7.2. Market Drivers
    • 7.2.1. Driving Factor 1 Analysis
    • 7.2.2. Driving Factor 2 Analysis
  • 7.3. Market Restraints
    • 7.3.1. Restraining Factor Analysis
  • 7.4. Market Opportunities
    • 7.4.1. Market Opportunity Analysis
  • 7.5. Porter’s Five Forces Analysis
  • 7.6. PEST Analysis
  • 7.7. Regulatory Landscape
  • 7.8. Technology Landscape
  • 7.9. Regional Market Trends
    • 7.9.1. North America
    • 7.9.2. Europe
    • 7.9.3. Asia Pacific
    • 7.9.4. Latin America
    • 7.9.5. The Middle-East and Africa
  • 7.10. Pricing Analysis
  • 7.11. Value Chain Analysis
  • 7.12. Downstream Buyers
  • 7.13. Distributors/Traders List
• Chapter No. 8 Competitive Landscape
  • 8.1. Company Market Share Analysis – 2019
    • 8.1.1. Global Neuroblastoma Treatment Market: Company Market Share, 2019
    • 8.1.2. Global Neuroblastoma Treatment Market, Company Market Revenue, 2016 – 2019 (USD Million)
    • 8.1.3. Global Neuroblastoma Treatment Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 8.1.4. Global Neuroblastoma Treatment Market: Radar Determinant Chart, 2019
  • 8.2. Strategic Developments
    • 8.2.1. Acquisitions & Mergers
    • 8.2.2. New Product Launch
    • 8.2.3. Regional Expansion
  • 8.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 9 Company Profiles
  • 9.1. United Therapeutics Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Product Portfolio
    • 9.1.4. Financial Overview
    • 9.1.5. Operating Business Segments
    • 9.1.6. Business Performance
    • 9.1.7. Recent Developments
  • 9.2. Apeiron Biulogics AG
  • 9.3. Baxter
  • 9.4. Cellectar Biosciences, Inc.
  • 9.5. Pfizer, Inc.
  • 9.6. MacroGenics, Inc.
  • 9.7. Bayer AG
  • 9.8. Sun Pharmaceutical Industries, Inc.
  • 9.9. Sartorius AG
• Chapter No. 10 Marketing Strategy Analysis
  • 10.1. Marketing Channel
  • 10.2. Direct Marketing
  • 10.3. Indirect Marketing
  • 10.4. Marketing Channel Development Trends
  • 10.5. Economic/Pulitical Environmental Change
• Chapter No. 11 Research Methodology
  • 11.1. Research Methodology
  • 11.2. Phase I - Secondary Research
  • 11.3. Phase II - Data Modeling
    • 11.3.1. Company Share Analysis Model
    • 11.3.2. Revenue Based Modeling
  • 11.4. Phase III - Primary Research
  • 11.5. Research Limitations
    • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Component
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By End Use Industry
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Neuroblastoma Treatment Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North American Countries
FIG NO. 7. Market Revenue Share, By Component, 2020 & 2028
FIG NO. 8. Global Neuroblastoma Treatment Market for Software, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Software, By Country, 2020 & 2028
FIG NO. 10. Global Neuroblastoma Treatment Market for Service, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Service, By Country, 2020 & 2028
FIG NO. 12. Global Neuroblastoma Treatment Market Revenue Share, By Application, 2020 & 2028
FIG NO. 13. Global Neuroblastoma Treatment Market for Marketing, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Marketing, By Country, 2020 & 2028
FIG NO. 15. Global Neuroblastoma Treatment Market for Operations, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Operations, By Country, 2020 & 2028
FIG NO. 17. Global Neuroblastoma Treatment Market for Finance, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Finance, By Country, 2020 & 2028
FIG NO. 19. Global Neuroblastoma Treatment Market for Human Resource, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Human Resource, By Country, 2020 & 2028
FIG NO. 21. Global Neuroblastoma Treatment Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Others, By Country, 2020 & 2028
FIG NO. 23. Global Neuroblastoma Treatment Market Revenue Share, By End Use Industry, 2020 & 2028
FIG NO. 24. Global Neuroblastoma Treatment Market for Manufacturing, Revenue (USD Million) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Manufacturing, By Country, 2020 & 2028
FIG NO. 26. Global Neuroblastoma Treatment Market for Hospitality, Revenue (USD Million) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Hospitality, By Country, 2020 & 2028
FIG NO. 28. Global Neuroblastoma Treatment Market for BFSI, Revenue (USD Million) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Neuroblastoma Treatment Market for BFSI, By Country, 2020 & 2028
FIG NO. 30. Global Neuroblastoma Treatment Market for Retail, Revenue (USD Million) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Retail, By Country, 2020 & 2028
FIG NO. 32. Global Neuroblastoma Treatment Market for IT & Telecom, Revenue (USD Million) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Neuroblastoma Treatment Market for IT & Telecom, By Country, 2020 & 2028
FIG NO. 34. Global Neuroblastoma Treatment Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Neuroblastoma Treatment Market for Others, By Country, 2020 & 2028
FIG NO. 36. Global Neuroblastoma Treatment Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Neuroblastoma Treatment Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 38. Porter’s Five Forces Analysis for Global Neuroblastoma Treatment Market
FIG NO. 39. PEST Analysis for Global Neuroblastoma Treatment Market
FIG NO. 40. Pricing Analysis for Global Neuroblastoma Treatment Market
FIG NO. 41. Value Chain Analysis for Global Neuroblastoma Treatment Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. Oracle Corporation Business Segment Revenue Share, 2020 (%)
FIG NO. 46. Oracle Corporation Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology 
 

Table Of Tables

List Of Tables 

TABLE NO. 1. Global Neuroblastoma Treatment Market: Snapshot
TABLE NO. 2. Quarterly Neuroblastoma Treatment Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Neuroblastoma Treatment Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Neuroblastoma Treatment Market for Software, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Neuroblastoma Treatment Market for Service, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Neuroblastoma Treatment Market for Marketing, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Neuroblastoma Treatment Market for Operations, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Neuroblastoma Treatment Market for Finance, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Neuroblastoma Treatment Market for Human Resource, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Neuroblastoma Treatment Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Neuroblastoma Treatment Market for Manufacturing, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Neuroblastoma Treatment Market for Hospitality, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Neuroblastoma Treatment Market for BFSI, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Neuroblastoma Treatment Market for Retail, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Neuroblastoma Treatment Market for IT & Telecom, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Neuroblastoma Treatment Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Neuroblastoma Treatment Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 20. North America Neuroblastoma Treatment Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 21. North America Neuroblastoma Treatment Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 22. North America Neuroblastoma Treatment Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Neuroblastoma Treatment Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 24. U.S. Neuroblastoma Treatment Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 25. U.S. Neuroblastoma Treatment Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 26. U.S. Neuroblastoma Treatment Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 27. Canada Neuroblastoma Treatment Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 28. Canada Neuroblastoma Treatment Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 29. Canada Neuroblastoma Treatment Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 30. Mexico Neuroblastoma Treatment Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 31. Mexico Neuroblastoma Treatment Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 32. Mexico Neuroblastoma Treatment Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 33. Drivers for the Neuroblastoma Treatment Market: Impact Analysis
TABLE NO. 34. Restraints for the Neuroblastoma Treatment Market: Impact Analysis
TABLE NO. 35. Major Buyers of Neuroblastoma Treatment
TABLE NO. 36. Distributors/Traders List of Neuroblastoma Treatment
TABLE NO. 37. Global Neuroblastoma Treatment Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 38. Global Neuroblastoma Treatment Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)